CN101417124B - 生物亲和性材料及其制造方法 - Google Patents
生物亲和性材料及其制造方法 Download PDFInfo
- Publication number
- CN101417124B CN101417124B CN2008101749498A CN200810174949A CN101417124B CN 101417124 B CN101417124 B CN 101417124B CN 2008101749498 A CN2008101749498 A CN 2008101749498A CN 200810174949 A CN200810174949 A CN 200810174949A CN 101417124 B CN101417124 B CN 101417124B
- Authority
- CN
- China
- Prior art keywords
- collagen
- hydroxyapatite
- fish scale
- complex
- biocompatible material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000560 biocompatible material Substances 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims description 70
- 238000004519 manufacturing process Methods 0.000 title claims description 54
- 230000008569 process Effects 0.000 title description 20
- 102000008186 Collagen Human genes 0.000 claims abstract description 116
- 108010035532 Collagen Proteins 0.000 claims abstract description 116
- 229920001436 collagen Polymers 0.000 claims abstract description 116
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims abstract description 103
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 103
- 241000251468 Actinopterygii Species 0.000 claims abstract description 102
- 239000011575 calcium Substances 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 23
- 229910052791 calcium Inorganic materials 0.000 claims description 19
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 18
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 11
- 229910052698 phosphorus Inorganic materials 0.000 claims description 11
- 239000011734 sodium Substances 0.000 claims description 11
- 229910052708 sodium Inorganic materials 0.000 claims description 11
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 10
- 239000011777 magnesium Substances 0.000 claims description 10
- 229910052749 magnesium Inorganic materials 0.000 claims description 10
- 239000011574 phosphorus Substances 0.000 claims description 10
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 9
- 238000007602 hot air drying Methods 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 239000000470 constituent Substances 0.000 claims description 5
- 150000002632 lipids Chemical class 0.000 claims description 3
- 239000000463 material Substances 0.000 abstract description 8
- 239000002131 composite material Substances 0.000 abstract 1
- 235000019688 fish Nutrition 0.000 description 92
- 239000007788 liquid Substances 0.000 description 90
- 210000000988 bone and bone Anatomy 0.000 description 52
- 238000012545 processing Methods 0.000 description 42
- 239000000243 solution Substances 0.000 description 37
- 238000000926 separation method Methods 0.000 description 34
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 30
- 238000000605 extraction Methods 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 230000000694 effects Effects 0.000 description 25
- 239000007787 solid Substances 0.000 description 19
- 108090000790 Enzymes Proteins 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 18
- 238000010306 acid treatment Methods 0.000 description 17
- 238000010010 raising Methods 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000004659 sterilization and disinfection Methods 0.000 description 15
- 238000010172 mouse model Methods 0.000 description 14
- 230000001954 sterilising effect Effects 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- 230000001054 cortical effect Effects 0.000 description 13
- 230000037182 bone density Effects 0.000 description 12
- 239000012530 fluid Substances 0.000 description 12
- 239000003513 alkali Substances 0.000 description 11
- 239000004677 Nylon Substances 0.000 description 10
- 238000001035 drying Methods 0.000 description 10
- 229920001778 nylon Polymers 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 9
- 230000008021 deposition Effects 0.000 description 9
- 238000010612 desalination reaction Methods 0.000 description 9
- 230000008520 organization Effects 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 239000004698 Polyethylene Substances 0.000 description 8
- IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 229940089617 risedronate Drugs 0.000 description 8
- 210000001694 thigh bone Anatomy 0.000 description 8
- 208000001132 Osteoporosis Diseases 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 238000004020 luminiscence type Methods 0.000 description 6
- 244000060011 Cocos nucifera Species 0.000 description 5
- 235000013162 Cocos nucifera Nutrition 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000005352 clarification Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000011033 desalting Methods 0.000 description 5
- 238000007598 dipping method Methods 0.000 description 5
- -1 polyethylene Polymers 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 241000252233 Cyprinus carpio Species 0.000 description 4
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 229910052586 apatite Inorganic materials 0.000 description 4
- 230000009849 deactivation Effects 0.000 description 4
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 4
- 210000002745 epiphysis Anatomy 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 229960002591 hydroxyproline Drugs 0.000 description 4
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 238000002798 spectrophotometry method Methods 0.000 description 4
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 4
- 241000194108 Bacillus licheniformis Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000009965 odorless effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000009967 tasteless effect Effects 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 238000007696 Kjeldahl method Methods 0.000 description 2
- 241000269795 Lateolabrax japonicus Species 0.000 description 2
- 208000006735 Periostitis Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
- 241000276707 Tilapia Species 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 230000037118 bone strength Effects 0.000 description 2
- 238000000326 densiometry Methods 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000001177 diphosphate Substances 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 210000003460 periosteum Anatomy 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000932075 Priacanthus hamrur Species 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IMBKASBLAKCLEM-UHFFFAOYSA-L ferrous ammonium sulfate (anhydrous) Chemical compound [NH4+].[NH4+].[Fe+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O IMBKASBLAKCLEM-UHFFFAOYSA-L 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000009806 oophorectomy Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001009 osteoporotic effect Effects 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 210000002356 skeleton Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007278908 | 2007-10-26 | ||
| JP2007-278908 | 2007-10-26 | ||
| JP2007278908A JP4369969B2 (ja) | 2007-10-26 | 2007-10-26 | 生体適合性材料並びにその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101417124A CN101417124A (zh) | 2009-04-29 |
| CN101417124B true CN101417124B (zh) | 2013-03-13 |
Family
ID=40583149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101749498A Active CN101417124B (zh) | 2007-10-26 | 2008-10-24 | 生物亲和性材料及其制造方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US8241671B2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4369969B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101299342B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101417124B (cg-RX-API-DMAC7.html) |
| TW (1) | TWI476011B (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090036656A1 (en) * | 2007-07-31 | 2009-02-05 | Body Organ Biomedical Corp. | Method for preparing a biomaterial |
| JP5336722B2 (ja) * | 2007-10-26 | 2013-11-06 | 株式会社アールビーエス | リン、カルシウム、マグネシウム、ナトリウム等のミネラル成分を含むハイドロキシアパタイトの製造方法並びにリン、カルシウム、マグネシウム、ナトリウム等のミネラル成分を含むハイドロキシアパタイト。 |
| JP4369969B2 (ja) * | 2007-10-26 | 2009-11-25 | 株式会社アールビーエス | 生体適合性材料並びにその製造方法 |
| JP5248848B2 (ja) * | 2007-12-11 | 2013-07-31 | 山八歯材工業株式会社 | インプラントの製造方法及び人工歯根の製造方法 |
| CN101480503B (zh) * | 2008-01-09 | 2012-10-17 | 柏登生医股份有限公司 | 配制生物材料的方法 |
| JP5350921B2 (ja) * | 2009-07-13 | 2013-11-27 | 株式会社アールビーエス | 生体適合性材料の製造方法並びに生体適合性材料並びに食品 |
| US20140066379A1 (en) * | 2012-08-30 | 2014-03-06 | Body Organ Biomedical Corp. | Recombinant vector, transgenic fish egg using the same and biomaterial using the same |
| KR101433242B1 (ko) * | 2012-11-16 | 2014-08-25 | 경북대학교 산학협력단 | 정복 시술 로봇 및 그의 구동 제어 방법 |
| US10383976B1 (en) | 2018-10-08 | 2019-08-20 | King Saud University | Method of fabricating nanostructures from fish waste |
| WO2025068767A1 (en) * | 2023-09-29 | 2025-04-03 | Salmoss Spa | Aquatic-derived hydroxyapatite biomaterials and related methods |
| CN121775215B (zh) * | 2026-03-03 | 2026-06-30 | 杭州芊浔生物科技有限公司 | 非交联鱼鳞源可注射凝胶及其制备方法和应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN87102744A (zh) * | 1986-08-05 | 1988-02-17 | 罗巴法姆股份公司 | 一种刺激软骨细胞和成骨细胞的组合物(骨胶原羟基磷灰石化合物),其制备方法以及含有该组合物的药品 |
| CN1628540A (zh) * | 2003-12-16 | 2005-06-22 | 威海市宇王水产有限公司 | 鱼鳞胶原蛋白的生产方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05155900A (ja) | 1991-09-30 | 1993-06-22 | Nippon Kasei Chem Co Ltd | 高純度の酸不溶性魚鱗コラーゲンおよびその製造法 |
| EP0842670A1 (en) * | 1996-11-13 | 1998-05-20 | Katsunari Nishihara | Biomedical materials |
| JPH10216214A (ja) * | 1996-11-13 | 1998-08-18 | Katsunari Nishihara | 医用材料 |
| JP2001211895A (ja) | 2000-02-04 | 2001-08-07 | Kenji Kida | 生理活性ペプチドの製造法 |
| JP4010484B2 (ja) | 2002-02-18 | 2007-11-21 | 株式会社成和化成 | 魚鱗由来加水分解コラーゲンの製造方法 |
| JP2003327599A (ja) | 2002-03-08 | 2003-11-19 | Nitta Gelatin Inc | 魚由来コラーゲン、その製造方法およびその用途 |
| KR100699324B1 (ko) * | 2003-02-19 | 2007-03-23 | 나카가와모모키 | 어린단백질 가수분해물의 제조방법 |
| JP2006067809A (ja) * | 2004-08-31 | 2006-03-16 | Shida Kanzume Kk | 炎症性サイトカインの製造方法 |
| CN100370033C (zh) * | 2005-10-19 | 2008-02-20 | 由守谊 | 一种鱼鳞胶原蛋白生产工艺 |
| JP5341299B2 (ja) * | 2005-12-28 | 2013-11-13 | 株式会社アールビーエス | コラーゲンの製造方法及び低分子コラーゲン |
| JP4369969B2 (ja) * | 2007-10-26 | 2009-11-25 | 株式会社アールビーエス | 生体適合性材料並びにその製造方法 |
-
2007
- 2007-10-26 JP JP2007278908A patent/JP4369969B2/ja active Active
-
2008
- 2008-10-21 TW TW097140274A patent/TWI476011B/zh not_active IP Right Cessation
- 2008-10-22 US US12/255,931 patent/US8241671B2/en active Active
- 2008-10-24 KR KR1020080104861A patent/KR101299342B1/ko not_active Expired - Fee Related
- 2008-10-24 CN CN2008101749498A patent/CN101417124B/zh active Active
-
2012
- 2012-04-16 US US13/447,832 patent/US8409622B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN87102744A (zh) * | 1986-08-05 | 1988-02-17 | 罗巴法姆股份公司 | 一种刺激软骨细胞和成骨细胞的组合物(骨胶原羟基磷灰石化合物),其制备方法以及含有该组合物的药品 |
| CN1628540A (zh) * | 2003-12-16 | 2005-06-22 | 威海市宇王水产有限公司 | 鱼鳞胶原蛋白的生产方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| US8241671B2 (en) | 2012-08-14 |
| KR101299342B1 (ko) | 2013-08-26 |
| JP2009107938A (ja) | 2009-05-21 |
| TWI476011B (zh) | 2015-03-11 |
| US20120251626A1 (en) | 2012-10-04 |
| CN101417124A (zh) | 2009-04-29 |
| KR20090042742A (ko) | 2009-04-30 |
| TW200927154A (en) | 2009-07-01 |
| US8409622B2 (en) | 2013-04-02 |
| JP4369969B2 (ja) | 2009-11-25 |
| US20090110748A1 (en) | 2009-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101417124A (zh) | 生物亲和性材料及其制造方法 | |
| JP2009107938A5 (cg-RX-API-DMAC7.html) | ||
| CN104958756B (zh) | 一种鳄鱼骨胶原螯合钙的制备方法 | |
| AU2009318621A1 (en) | Fracture repair promoter | |
| CN115669839B (zh) | 一种牛骨胶原肽-钙螯合固体饮料及其制备方法 | |
| CN106213492A (zh) | 一种提升运动机能并增加骨密度的健康产品及制备方法 | |
| CA2209848C (en) | Pharmaceutical and dietary composition containing sodium, potassium, magnesium and calcium ions and enzyme activators | |
| US5897881A (en) | Hard tissue intactly dissolved materials and method for producing the same | |
| US20020090400A1 (en) | Putamen ovi | |
| JP5350921B2 (ja) | 生体適合性材料の製造方法並びに生体適合性材料並びに食品 | |
| JP2660906B2 (ja) | ウニ由来カルシウムの製造方法ならびにこの製造方法によって得られる易吸収性カルシウムを含有する組成物 | |
| RU2270586C2 (ru) | Пищевая кальцийсодержащая добавка и функциональный пищевой продукт ее содержащий | |
| CN1193770C (zh) | 一种鹿茸药用成分的水解提取方法及产品 | |
| CN1927803A (zh) | 一种利用牡蛎壳作钙源制备丙酸钙、乳酸钙的方法 | |
| JPH05161480A (ja) | アミノ酸を配合したカルシウム組成物およびそれを含有するカルシウム飲料 | |
| JP2009242422A5 (cg-RX-API-DMAC7.html) | ||
| CN109078164B (zh) | 灰星鲨鱼皮混合型蛋白肽作为骨骼发育促进剂和微量元素补充剂的应用 | |
| JPH0947253A (ja) | 易吸収性カルシウムを含有する組成物およびその製造 方法 | |
| CA2128042C (en) | Calcium containing compositions with high oral bioavailability, manufacturing method of such a composition, health food containing such a composition, and pharmaceutical composition containing such a composition | |
| CN121622872A (zh) | 一种钙和胶原蛋白的组合物及在骨骼关节健康上的用途 | |
| JP2011073999A (ja) | 骨密度増強剤 | |
| JP4382836B2 (ja) | ミネラル剤及びその製造方法 | |
| JP2013224277A (ja) | 経口骨強化組成物及びそれを含有する飲食品、医薬又は飼料 | |
| KR101099921B1 (ko) | 풍미가 향상된 유산균증식제 제조방법 | |
| JP6692183B2 (ja) | 骨強化促進用組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |